首页 | 本学科首页   官方微博 | 高级检索  
检索        

珊瑚共附生黄柄曲霉次级代谢产物研究
引用本文:王洪亮,姜文丽,李冉,许聪聪,张文.珊瑚共附生黄柄曲霉次级代谢产物研究[J].药学实践杂志,2019,37(2):151-155.
作者姓名:王洪亮  姜文丽  李冉  许聪聪  张文
作者单位:海军军医大学药学院 上海 200433;陆军军医大学士官学校, 河北 石家庄 050000,海军军医大学药学院 上海 200433,海军军医大学药学院 上海 200433,安徽中医药大学, 安徽 合肥 230000,海军军医大学药学院 上海 200433
基金项目:国家自然科学基金(41576157)
摘    要:目的 研究东沙短足软珊瑚(Cladiella sp.)来源的黄柄曲霉菌(Aspergillus flavipes)中的活性次级代谢产物。方法 采用硅胶柱层析、凝胶柱层析、制备HPLC等分离手段对真菌发酵液乙酸乙酯提取物进行分离,运用现代波谱技术结合文献报道数据,对化合物的结构进行鉴定;采用核因子κB受体活化因子配基(RANKL)诱导小鼠骨髓单核巨噬细胞(bone marrow macrophage cells,BMMs)分化为成熟的破骨细胞,经抗酒石酸酸性磷酸酶(TRAP)特异性染色,对化合物抑制破骨细胞分化活性进行研究。结果 从该株真菌中分离得到4个细胞松弛素类化合物,其结构鉴定为trichalasins H,aspergilluchalasin,aspochalasin I和aspochalasin D。体外活性测试结果显示,化合物3和4可不同程度抑制BMMs向破骨细胞分化。结论 对化合物3和4抑制破骨细胞分化活性的报告是本文首次报道,对新型抗骨质疏松活性物质研究具有科学价值。

关 键 词:珊瑚共附生真菌  黄柄曲霉  细胞松弛素  抑制破骨细胞分化
收稿时间:2018/11/4 0:00:00
修稿时间:2019/3/4 0:00:00

Study on the secondary metabolites of Aspergillus flavipes isolated from coral
WANG Hongliang,JIANG Wenli,LI Ran,XU Congcong and ZHANG Wen.Study on the secondary metabolites of Aspergillus flavipes isolated from coral[J].The Journal of Pharmaceutical Practice,2019,37(2):151-155.
Authors:WANG Hongliang  JIANG Wenli  LI Ran  XU Congcong and ZHANG Wen
Institution:Research Center for Marine Drugs, School of Pharmacy, Naval Medical University, Shanghai 200433, China;Sergeant School of Army Medical University, Shijiazhuang 050000, China,Research Center for Marine Drugs, School of Pharmacy, Naval Medical University, Shanghai 200433, China,Research Center for Marine Drugs, School of Pharmacy, Naval Medical University, Shanghai 200433, China,Anhui University of Chinese Medicine, Hefei 230038, China and Research Center for Marine Drugs, School of Pharmacy, Naval Medical University, Shanghai 200433, China
Abstract:Objective To investigate the active secondary metabolites of coral derived fungi Aspergillus flavipes.Methods Compounds were isolated and purified by means of various chromatographic techniques,including Silica gel column chromatography,Sephadex LH-20 chromatography and HPLC.The structure of the compounds was identified by NMR combined with the data reported.The nuclear factor kappa B receptor activating factor ligand (RANKL) was used to induce bone marrow macrophage cells (BMMs) differentiate into mature osteoclasts.The tartrate-resistant acid phosphatase (TRAP) specific staining was used to test the inhibitory activity of compounds on osteoclast differentiation.Results Four cytochalasins were isolated from the fungus and their structures were identified as trichalasins H,aspergilluchalasin,aspochalasin I and aspochalasin D.Compounds 3 and 4 showed inhibitory activity on osteoclast differentiation.Conclusion This was the first report of inhibiting osteoclast differentiation activity of compounds 3 and 4.These two compounds might have great significance in the study of new anti-osteoporosis drugs.
Keywords:coral derived fungi  Aspergillus flavipes  cytochalasin  inhibit osteoclast differentiation
点击此处可从《药学实践杂志》浏览原始摘要信息
点击此处可从《药学实践杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号